Breaking Research News from Breastcancer.org
Comments
-
Changing
Chemo Regimens Doesn’t Seem to Help Women Diagnosed With Metastatic
Breast Cancer With High Levels of Circulating Tumor Cells
February 13, 2014
Switching chemotherapy regimens doesn’t seem to improve the outcomes of
women diagnosed with metastatic breast cancer with high levels of
circulating tumor cells. Read more...0 -
Canadian Study Questions Value Of Mammograms for Women Aged 40 to 59; Experts Say Research Is Flawed
February 13, 2014
A large Canadian study questions the value of mammograms, but many experts say the study is flawed and misleading. Read more…0 -
I think readers of the link should know who at bco wrote the position attached to the Canadian study and should disclose their affiliations.
0 -
I agree voracious, wasn't one of the key points in the discussion section of the study about mortality of the women with non palpable lumps found with the mammograms compared with the control group? Better mammography equipment or radiologist training wouldn't have made any difference here.
Full disclosure - I was a part of this study, joined after turning 40 in 1984. I was dx with ILC at age 65 through a screening mammogram.
0 -
Older Women More Likely to Need Mastectomy After Brachytherapy
February 19, 2014
Research suggests older women who have brachytherapy after lumpectomy
are more likely to have a mastectomy 5 years after surgery compared to
women who had traditional external beam radiation therapy. Read more...0 -
FDA Says Ductal Lavage Shouldn't Be Used in Place of Mammograms
February 20, 2014
The FDA has warned women and doctors that ductal lavage, also known as a
nipple aspirate test, isn’t a replacement for mammograms, other breast
imaging tests, or breast biopsy and shouldn’t be used by itself to
screen for or diagnose breast cancer. Read more...0 -
U.S. Task Force Recommends Women at High Risk Get BRCA Testing
February 20, 2014
U.S. Task Force recommends that undiagnosed women at high risk for
breast cancer because of family history of breast or ovarian cancer
should be offered genetic counseling and genetic testing by their
primary care doctors to see if they have an abnormal BRCA1 or BRCA2
gene. Read more...0 -
Research Suggests Lumpectomy Plus Radiation Leads to Better Survival for Early-Stage Breast Cancer but There Are Questions About Study
February 20, 2014
A study suggests that women diagnosed with stage I or stage II breast
cancer who have lumpectomy followed by radiation have better survival
rates than women who have mastectomy alone or mastectomy plus radiation. Read more...0 -
Best to Start Chemotherapy Within 30 Days of Surgery
February 20, 2014
A study suggests that women who wait more than 60 days after surgery to
start chemotherapy are more likely to have the cancer come back
someplace in the body away from the breast (metastasize) and also are
less likely to survive compared to women who start chemotherapy within
30 days of surgery. Read more...0 -
Yoga Seems to Ease Fatigue, Reduce Inflammation in Diagnosed Women
February 21, 2014
A small study suggests that practicing yoga for as little as 3 months
can ease fatigue and reduce inflammation in women diagnosed with
early-stage breast cancer. Read more...0 -
Counseling Plus Hypnosis Helps Ease Fatigue in Women Getting Radiation Therapy
February 21, 2014
A small study has found that a specific type of counseling called
cognitive behavioral therapy, along with hypnosis, can help ease the
fatigue that often can be a side effect of radiation therapy to treat
breast cancer. Read more...0 -
Acupuncture Helps Ease Side Effects From Aromatase Inhibitors
February 21, 2014
A small study suggests both real and placebo acupuncture can help ease aromatase inhibitor side effects. Read more...0 -
Hormonal Infertility Treatments Don't Seem to Affect Risk
February 21, 2014
A large study shows that infertility treatments don’t appear to increase breast cancer risk. Read more...0 -
Benign Breast Disease Increases Risk
March 7, 2014
A study has found that two types of benign breast disease -- atypical
ductal hyperplasia and atypical lobular hyperplasia -- increase the risk
of breast cancer in the same breast by about the same amount. Read more...0 -
More Women Having Reconstruction; Implants Being Used More
March 7, 2014
A study looking at reconstruction statistics over time found that more
U.S. women are having reconstruction after mastectomy and more women are
choosing implants over autologous reconstruction. Read more...0 -
Long-Term Survivors Need All-Encompassing Care
March 7, 2014
A study suggests that whether or not older women who’ve been treated for
breast cancer develop high blood pressure, heart disease, or
osteoporosis is affected by the breast cancer treatments they receive,
as well as their weight and age. Read more...0 -
Women With Abnormal BRCA1 or BRCA2 Gene Benefit From Ovary Removal But at What Age?
March 7, 2014
A study suggests that women with an abnormal BRCA1 or BRCA2 gene have an
80% lower risk of ovarian cancer if they have both ovaries removed
preventively. Read more...0 -
Most Young Diagnosed Women Concerned About Fertility, Few Take Advantage of Preservation Techniques
March 7, 2014
Research suggests that while most younger women diagnosed with breast
cancer are concerned about fertility issues, few of them change their
treatment plans to preserve fertility. Fewer still take advantage of
fertility preservation options. Read more...0 -
Low Vitamin D Levels Linked to Worse Survival
March 24, 2014
A study suggests a link between higher vitamin D levels in the blood and better breast cancer survival. Read more...0 -
Radiation After Mastectomy Offers Benefits if Breast Cancer Has Spread to One to Three Lymph Nodes
March 26, 2014
Research suggests that women diagnosed with early-stage breast cancer
that has spread to one to three lymph nodes are less likely to have a
recurrence and more likely to survive breast cancer if they have
radiation after mastectomy. Read more...0 -
This conclusion is an analysis that involves women from "14 studies that started between 1964 and 1982" - a lot has changed in the way we treat breast cancer, particularly hormone positive breast cancer since these women were treated - did we even have Tamoxifen and Aromatase Inhibitors way back then? 1964 is 50 years ago...
0 -
Maureen, that is a limitation to this study and the authors stated that as well.
0 -
New Guidelines Say Lumpectomy Margins Can Be Small as Long as Tumor Has No Ink on It
April 2, 2014
To establish a standard for lumpectomy margins, the American Society for
Radiation Oncology and the Society of Surgical Oncology issued new
guidelines saying that clear margins, no matter how small as long as
there was no ink on the cancer tumor, should be the standard for
lumpectomy surgery. Read more...0 -
I saw this article a few weeks back and was so relieved as I was left with a 0.4MM margin last year after my lumpectomy . My surgeon was already following the new guidelines of "no tumor on the ink " . She did not recommend a re-incision. She was aware of these new guidelines last yr. after some convention that she had attended . I was so glad to finally read about this as i have been having anxiety about the close margins ever since. This article make me feel soooo much better . Thanks Mods for posting .
0 -
Poohbear, we're happy this helps!!! Thanks for your note -- it means a lot
0 -
Mods - let me add my thanks for this thread. I look forward to your new articles and appreciate you doing the research to find them.
0 -
MinusTwo -- we appreciate your appreciation, too!
0 -
Experimental Palbociclib May Help Treat Estrogen-Receptor-Positive, HER2-Negative Advanced-Stage Breast Cancer
April 9, 2014
An early study suggests that the experimental medicine palbociclib in
combination with Femara offers more benefits in treating advanced-stage,
estrogen-receptor-positive, HER2-negative breast cancer than Femara
alone. Read more...0 -
I might have overlooked it, but does the article define "advanced stage"? Was this study on women with metastic breast cancer?
0 -
gemini4, a look at the Presentation Abstract from the AACR meeting shows that the study was on women with metastatic breast cancer.
Hope this helps.
0